FDA Approved: LYLLANA — Supplemental Application (Amneal Pharmaceuticals LLC)

View source ↗

Summary

FDA approved a supplemental application for LYLLANA (estradiol) from Amneal Pharmaceuticals LLC (ANDA 211396).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoestrogenism
• Menopause
• Postmenopausal Osteoporosis

Drugs mentioned

• LYLLANA (ESTRADIOL)

Snippet

SUPPL AP for LYLLANA (ESTRADIOL)